Opendata, web and dolomites

GlucoTab

A Novel ICT Assistant Solution for de-Risked Management of Insulin Dosing and Blood Glucose Levels in Hospitalized Patients with Type 2 Diabetes

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 GlucoTab project word cloud

Explore the words cloud of the GlucoTab project. It provides you a very rough idea of what is the project "GlucoTab" about.

impacted    therapy    solution    adaptable    guidelines    medical    disease    hazardous    automate    regimen    turn    decision    becomes    wrong    hospitals    cumulative    bedside    believe    glucose    assist    incurred    diabetic    least    multiple    market    enrolling    wards    flexible    lack    responsible    integration    13    suitable    combining    basal    inefficient    created    blood    precise    software    centric    easing    stay    despite    saturated    suffer    rely    clinical    prescription    600    encloses    persistent    dosing    day    complicated    42    admissions    arduous    beds    50    patients    overwhelming    error    risk    secretion    conceived    launch    adjustments    full    medication    hospital    flow    recommend    reducing    mimic    treatment    efficient    ups    risks    hyperglycemia    charts    decisions    incorrect    bolus    follow    incidence    hypoglycemia    healthcare    days    rising    insulin    revenues    guidance       extremely    workload    patient    ict    care    glucotab    daily    judgment    standardize    physiological    calculations    device    errors    alarming    diabetes    paper   

Project "GlucoTab" data sheet

The following table provides information about the project.

Coordinator
DECIDE CLINICAL SOFTWARE GMBH 

Organization address
address: NEUE STIFTINGTALSTRASSE 2
city: GRAZ
postcode: 8010
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Austria [AT]
 Project website http://www.glucotab.at
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.2.1.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT))
2. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
 Code Call H2020-SMEINST-1-2016-2017
 Funding Scheme SME-1
 Starting year 2016
 Duration (year-month-day) from 2016-11-01   to  2017-02-28

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    DECIDE CLINICAL SOFTWARE GMBH AT (GRAZ) coordinator 50˙000.00

Map

 Project objective

'Despite being responsible for up to 1/3 of admissions, the management of type 2 diabetes in hospital wards is still extremely challenging. European clinical guidelines recommend prescription of 'basal-bolus insulin therapy' as it is the most flexible, adaptable and precise regimen available to mimic the physiological secretion of insulin. However, it requires a patient-centric approach with multiple daily follow-ups. Since both persistent hypoglycemia (due to incorrect medication) and hyperglycemia (due to disease) are hazardous, diabetic care requires day-to-day decisions combining medical judgment and clinical findings. This overwhelming task is even more complicated due to the current inefficient methods that rely on by-hand calculations and paper-based charts. Thus, management becomes a complex task, increasing the workload for the already saturated personnel. Most importantly, it increases the overall risk of medical errors. Indeed, 42% in-hospital days are impacted by treatment errors, wrong blood glucose measurements or lack of adjustments on insulin dosing. Thus, 50% of patients suffer at least one medication error during their stay. In response, we have created GlucoTab, an ICT-based software able to assist on the arduous decision-making process daily incurred in the management of type 2 diabetes. GlucoTab will automate and standardize task management, reducing risks, costs and easing the personnel's work-flow. Conceived as a medical device, our product is able to offer guidance on the most suitable insulin dosing regimen for a patient. By enabling the full integration of the patient's bedside management with the general hospital information system, we believe that GlucoTab encloses a cost-efficient solution that will allow hospitals and healthcare systems to face the alarming rising incidence of diabetes. In turn, GlucoTab will provide us estimated cumulative revenues of €7.7 M after enrolling 13,600 beds within five years from market launch.'

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "GLUCOTAB" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "GLUCOTAB" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.2.1.1.;H2020-EU.2.3.1.)

REALM (2015)

A disruptive method to free physicians from Hospital Information Systems by generating fault free patient diagnostic documents in real-time using natural language

Read More  

OKIDOKEYS (2015)

New electro-mechanic access system with dematerialized keys for residential market

Read More  

SOFT (2017)

SOFT, the first camera-based colorectal cancer screening test to detect occult blood in faeces immediately and with no lab analysis.

Read More